收费全文 | 942320篇 |
免费 | 68500篇 |
国内免费 | 1456篇 |
耳鼻咽喉 | 13048篇 |
儿科学 | 24778篇 |
妇产科学 | 23485篇 |
基础医学 | 134168篇 |
口腔科学 | 28604篇 |
临床医学 | 81201篇 |
内科学 | 186180篇 |
皮肤病学 | 19535篇 |
神经病学 | 73244篇 |
特种医学 | 37312篇 |
外国民族医学 | 79篇 |
外科学 | 154177篇 |
综合类 | 18087篇 |
现状与发展 | 1篇 |
一般理论 | 235篇 |
预防医学 | 61697篇 |
眼科学 | 21510篇 |
药学 | 73502篇 |
3篇 | |
中国医学 | 2141篇 |
肿瘤学 | 59289篇 |
2018年 | 9352篇 |
2017年 | 7312篇 |
2016年 | 8100篇 |
2015年 | 9245篇 |
2014年 | 12456篇 |
2013年 | 18078篇 |
2012年 | 24945篇 |
2011年 | 26009篇 |
2010年 | 15352篇 |
2009年 | 14724篇 |
2008年 | 25381篇 |
2007年 | 26619篇 |
2006年 | 27349篇 |
2005年 | 26340篇 |
2004年 | 25407篇 |
2003年 | 24339篇 |
2002年 | 23916篇 |
2001年 | 55039篇 |
2000年 | 56766篇 |
1999年 | 47106篇 |
1998年 | 10456篇 |
1997年 | 9110篇 |
1996年 | 9279篇 |
1995年 | 8995篇 |
1994年 | 8362篇 |
1993年 | 7681篇 |
1992年 | 35715篇 |
1991年 | 34144篇 |
1990年 | 32953篇 |
1989年 | 32076篇 |
1988年 | 29159篇 |
1987年 | 28418篇 |
1986年 | 26445篇 |
1985年 | 25298篇 |
1984年 | 17944篇 |
1983年 | 15201篇 |
1982年 | 7835篇 |
1981年 | 6796篇 |
1979年 | 15866篇 |
1978年 | 10657篇 |
1977年 | 9096篇 |
1976年 | 7910篇 |
1975年 | 8684篇 |
1974年 | 10528篇 |
1973年 | 9912篇 |
1972年 | 9415篇 |
1971年 | 8904篇 |
1970年 | 8481篇 |
1969年 | 7979篇 |
1968年 | 7270篇 |
Objectives
To estimate the incidence of all-cause outpatient community-acquired pneumonia (CAP) in adults in France from a national prospective observational study of CAP management in general practice (CAPA).Methods
Patients aged over 18 years presenting with signs or symptoms indicative of CAP associated with recent onset of unilateral crackles on auscultation and/or a new opacity on chest X-ray were included in the CAPA study. An ancillary survey (AIMSIS) aiming at identifying family physicians’ difficulties in including patients and at collecting their opinion on the use of an electronic case report form, determined the number of non-included eligible patients. A three-step analysis was then performed, including computation of the total number of eligible patients, adjustment for seasonality, and extrapolation to the French FP population using indirect standardization to adjust for differences in characteristics between CAPA FPs and French FPs.Results
Between September 2011 and July 2012, 267 (63%) CAPA investigators included 886 CAP patients. Most patients presented with mild CAP. The rates of hospitalization and one-month case fatality were 7% and 0.3%, respectively. Data from 336 (79%) AIMSIS investigators identified 641 additional patients and estimated at 234,023 the number of CAP patients per year (incidence of 4.7 per 1000 persons per year).Conclusions
Using a pragmatic case definition of CAP patients, this study estimated an incidence of 4.7 per 1000 persons per year that is in the lower half of the range of estimated incidences reported in primary care settings in industrialized countries. 相似文献Challenges lie in finding the optimal balance between the risk of bleeding and preventing thrombotic complications such as reinfarction or stent thrombosis. During the last decade, bivalirudin was introduced as a valid alternative to heparin for patients undergoing primary percutaneous coronary intervention. Several trials have been conducted to identify the agent with the best antithrombotic results at the lowest bleeding complication rate. In a rapidly evolving field with changes in vascular access, available P2Y12 inhibitors, and indications for glycoprotein IIb/IIIa inhibitor administration, conflicting evidence became available.
Areas covered: This paper mainly focuses on the evidence above and gives brief discussion to the recent literature on anticoagulation in fibrinolytic therapy and advances in antiplatelet therapy.
Expert opinion: To date, no robust evidence is available challenging unfractionated heparin as the primary choice for anticoagulation in patients presenting with ST-segment elevation myocardial infarction. Further research should include efforts to refine anticoagulation strategies on an individual patient level. For patients undergoing primary percutaneous coronary intervention, bivalirudin could be used as an alternative to unfractionated heparin, while enoxaparin or fondaparinux is an alternative agent for patients treated with fibrinolytic therapy. 相似文献